Data from the Colorado Central Cancer Registry shows Routt County had the highest rate of prostate cancer among all Colorado ...

The identification of 20 causal plasma proteins for prostate cancer represents a critical step toward addressing the need for improved diagnostic specificity and reveals promising new targets for ...

The targeted radiotherapies for cancer market is experiencing significant growth, driven by advancements in technology and ...

Johnson & Johnson is paying $3.05 billion to acquire Halda Therapeutics, obtaining a novel cell death platform while ...

"Grey's Anatomy" star James Pickens Jr. revealed his prostate cancer diagnosis, sharing a public service announcement on the ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...

Despite SBRT to oligometastatic sites, prostate cancer progression still occurs in a majority of patients due to occult microscopic disease.

Q3 2025 Earnings Call Transcript November 10, 2025 FibroGen, Inc. beats earnings expectations. Reported EPS is $-1.61, ...

Preclinical data support best-in-class potential of masked T cell engager programs and platform utilizing Xilio’s ATACR and SEECR formats, ...

Q3 2025 Earnings Call Transcript November 6, 2025 Lantheus Holdings, Inc. misses on earnings expectations. Reported EPS is $0 ...

Lantheus Holdings, Inc. ( LNTH) Q3 2025 Earnings Call November 6, 2025 8:00 AM EST ...

Lutetium Lu 177 vipivotide tetraxetan combined with ARPI and ADT improved rPFS in PSMA-positive mHSPC patients compared to ARPI and ADT alone. Lutetium Lu 177 vipivotide tetraxetan significantly ...